GLRX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.701800E-01
Normal-vs-Stage2
5.927200E-01
Normal-vs-Stage3
9.734800E-01
Normal-vs-Stage4
3.030000E-01
Stage1-vs-Stage2
4.619800E-01
Stage1-vs-Stage3
8.084400E-01
Stage1-vs-Stage4
3.086000E-01
Stage2-vs-Stage3
5.019400E-01
Stage2-vs-Stage4
1.061220E-01
Stage3-vs-Stage4
3.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.852600E-01
Normal-vs-AfricanAmerican
9.056800E-01
Normal-vs-Asian
9.816000E-01
Caucasian-vs-AfricanAmerican
2.591600E-01
Caucasian-vs-Asian
1.793430E-01
AfricanAmerican-vs-Asian
9.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.873400E-01
Normal-vs-Female
4.931600E-01
Male-vs-Female
1.761440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.413600E-01
Normal-vs-Age(41-60Yrs)
3.218200E-01
Normal-vs-Age(61-80Yrs)
7.155600E-01
Normal-vs-Age(81-100Yrs)
4.255000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.084600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.711000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.251800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.977700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.003580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.923800E-01
Normal-vs-Daily Drinker
4.480000E-01
Normal-vs-Weekly Drinker
6.296200E-01
Normal-vs-Occasional Drinker
2.731600E-01
Normal-vs-Social Drinker
6.847400E-01
Non Drinker-vs-Daily Drinker
6.186000E-01
Non Drinker-vs-Weekly Drinker
8.662000E-01
Non Drinker-vs-Occasional Drinker
2.300800E-01
Non Drinker-vs-Social Drinker
8.696800E-01
Daily Drinker-vs-Weekly Drinker
8.010600E-01
Daily Drinker-vs-Occasional Drinker
4.099200E-01
Daily Drinker-vs-Social Drinker
8.198800E-01
Weekly Drinker-vs-Occasional Drinker
3.745800E-01
Weekly Drinker-vs-Social Drinker
9.979600E-01
Occasional Drinker-vs-Social Drinker
4.182000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.514200E-01
Normal-vs-Grade 2
9.596000E-01
Normal-vs-Grade 3
9.693800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.915000E-01
Grade 1-vs-Grade 3
7.847400E-01
Grade 1-vs-Grade 4
9.514200E-01
Grade 2-vs-Grade 3
7.746600E-01
Grade 2-vs-Grade 4
9.596000E-01
Grade 3-vs-Grade 4
9.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.293800E-01
Normal-vs-NonDiabetic
4.906000E-01
Diabetic-vs-NonDiabetic
4.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.965600E-01
Normal-vs-NoPancreatitis
5.187000E-01
Pancreatitis-vs-NoPancreatitis
8.741000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.634200E-01
Normal-vs-N1
5.334400E-01
N0-vs-N1
8.976200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.971020E-01
Normal-vs-TP53-NonMutant
8.055600E-01
TP53-Mutant-vs-TP53-NonMutant
2.116200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
